Gabriele Peyerl-Hoffmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gabriele Peyerl-Hoffmann has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Christoph Hatz
20Swiss Tropical Institute, Basel, Switzerland
2 shared publications - Hermann Laferl
194. Medizinische Abteilung mit Infektions- und Tropenmedizin, Kaiser-Franz-Josef-Spital der Stadt Wien, Vienna, Austria
2 shared publications - Herwig Kollaritsch
Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria
2 shared publications - Ida Gjørup
Department of Infectious Diseases, Rigshospitalet, University of Copenhagen; Denmark
2 shared publications - Joaquim Gascon
Barcelona Institute for Global Health (ISGlobal), Hospital Clínic—University of Barcelona, Barcelona, Spain
2 shared publications - Juan Cuadros-González
Clinical Microbiology Department, Príncipe de Asturias University Hospital, 28805 Alcalá de Henares, Madrid, Spain
2 shared publications
Latest Publications
- Open Access
- 25 June 2003
- Published by Springer Nature in Malaria Journal
- Vol. 2 (1) , 17
Molecular surveillance of the antifolate-resistant mutation I164L in imported african isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop
Malaria parasites that carry the DHFR-mutation I164L are not only highly resistant to sulfadoxine-pyrimethamine but also to the new antimalarial drug chlorproguanil-dapsone. The spread of this mutation in Africa would result in a public health disaster since there is a lack of effective alternatives that are both affordable and safe. Up to now, this mutation has only been described in Asian and Latin-American countries. The objective of this study was to assess the prevalence of this mutation in African isolates of Plasmodium falciparum that have been imported into Europe through travellers.
- 25 June 2003
- Published by Springer Nature in Malaria Journal
- Vol. 2 (1) , 17
Open AccessMolecular surveillance of the antifolate-resistant mutation I164L in imported african isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop
Malaria parasites that carry the DHFR-mutation I164L are not only highly resistant to sulfadoxine-pyrimethamine but also to the new antimalarial drug chlorproguanil-dapsone. The spread of this mutation in Africa would result in a public health disaster since there is a lack of effective alternatives that are both affordable and safe. Up to now, this mutation has only been described in Asian and Latin-American countries. The objective of this study was to assess the prevalence of this mutation in African isolates of Plasmodium falciparum that have been imported into Europe through travellers.
- Open Access
- 1 January 2002
- Published by Springer Nature in Malaria Journal
- Vol. 1 (1) , 11
Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe
Results from numerous studies point convincingly to correlations between mutations at selected genes and phenotypic resistance to antimalarials in Plasmodium falciparum isolates. In order to move molecular assays for point mutations on resistance-related genes into the realm of applied tools for surveillance, we investigated a selection of P. falciparum isolates that were imported during the year 2001 into Europe to study the prevalence of resistance-associated point mutations at relevant codons. In particular, we tested for parasites which were developing resistance to antifolates and chloroquine. The screening results were used to map the prevalence of mutations and, thus, levels of potential drug resistance in endemic areas world-wide. 337 isolates have been tested so far. Prevalence of mutations that are associated with resistance to chloroquine on the pfcrt and pfmdr genes of P. falciparum was demonstrated at high levels. However, the prevalence of mutations associated with resistance to antifolates at the DHFR and DHPS genes was unexpectedly low, rarely exceeding 60% in endemic areas. Constant screening of imported isolates will enable TropNetEurop to establish a screening tool for emerging resistance in endemic areas.
- 1 January 2002
- Published by Springer Nature in Malaria Journal
- Vol. 1 (1) , 11
Open AccessMolecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe
Results from numerous studies point convincingly to correlations between mutations at selected genes and phenotypic resistance to antimalarials in Plasmodium falciparum isolates. In order to move molecular assays for point mutations on resistance-related genes into the realm of applied tools for surveillance, we investigated a selection of P. falciparum isolates that were imported during the year 2001 into Europe to study the prevalence of resistance-associated point mutations at relevant codons. In particular, we tested for parasites which were developing resistance to antifolates and chloroquine. The screening results were used to map the prevalence of mutations and, thus, levels of potential drug resistance in endemic areas world-wide. 337 isolates have been tested so far. Prevalence of mutations that are associated with resistance to chloroquine on the pfcrt and pfmdr genes of P. falciparum was demonstrated at high levels. However, the prevalence of mutations associated with resistance to antifolates at the DHFR and DHPS genes was unexpectedly low, rarely exceeding 60% in endemic areas. Constant screening of imported isolates will enable TropNetEurop to establish a screening tool for emerging resistance in endemic areas.
- Open Access
- 1 August 2001
- Published by Wiley in Tropical Medicine & International Health
- Vol. 6 (8) , 607-613
Genetic diversity of Plasmodium falciparum and its relationship to parasite density in an area with different malaria endemicities in West Uganda
Field populations of Plasmodium falciparum can be effectively genotyped by PCR‐amplification of selected fragments of the Merozoite Surface Proteins 1 and 2 (MSP1 and MSP2). Genetic diversity of P. falciparum populations in areas with different transmission levels (holo‐ vs. mesoendemic) was investigated in Kabarole District, West Uganda. 225 samples positive for P. falciparum were analysed by amplification of polymorphic regions and classified according to prevalence of allelic families. A large number of alleles was detected for each locus: 22 for MSP1 block 2 and 24 for MSP2 and, 175 (78%) of MSP1 alleles and 143 (64%) of MSP2 showed multiple infections within a range of 2–8 clones. Significant differences between holoendemic and mesoendemic areas in regards of population structure and number of multiclonal infections of P. falciparum were not apparent. However, a significant correlation between parasite density, selected MSP2 loci and differences between parasite density in monoclonal vs. multiclonal infections occurred. Multiplicity of infection was age‐dependent.
- 1 August 2001
- Published by Wiley in Tropical Medicine & International Health
- Vol. 6 (8) , 607-613
Open AccessGenetic diversity of Plasmodium falciparum and its relationship to parasite density in an area with different malaria endemicities in West Uganda
Field populations of Plasmodium falciparum can be effectively genotyped by PCR‐amplification of selected fragments of the Merozoite Surface Proteins 1 and 2 (MSP1 and MSP2). Genetic diversity of P. falciparum populations in areas with different transmission levels (holo‐ vs. mesoendemic) was investigated in Kabarole District, West Uganda. 225 samples positive for P. falciparum were analysed by amplification of polymorphic regions and classified according to prevalence of allelic families. A large number of alleles was detected for each locus: 22 for MSP1 block 2 and 24 for MSP2 and, 175 (78%) of MSP1 alleles and 143 (64%) of MSP2 showed multiple infections within a range of 2–8 clones. Significant differences between holoendemic and mesoendemic areas in regards of population structure and number of multiclonal infections of P. falciparum were not apparent. However, a significant correlation between parasite density, selected MSP2 loci and differences between parasite density in monoclonal vs. multiclonal infections occurred. Multiplicity of infection was age‐dependent.